The Global Cannabis Regulatory Summit (GCRS) has published a 100-page white paper that diagnoses a fragmented global regulatory landscape and sets out a working architecture to address it.
Tilray Medical, a global leader in medical cannabis research, cultivation, production, products and distribution and a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), today announced its participation in Cannabis Europa London 2026, one of Europe’s leading forums for medical cannabis policy, science, and regulation.
Cannabis Europa London returns on 26-27 May 2026, bringing together operators, investors, clinicians and policymakers from across the global cannabis industry for two days of main stage debate, exhibition, and networking.
Cannabis Europa London returns on 26-27 May 2026, bringing together operators, investors, clinicians, and policymakers from across the global cannabis industry for two days of main-stage debate, exhibition, and networking.
Canadian producers shipped 17,067kg of medical cannabis directly to the UK in 2025, more than six times the 2,578kg recorded the year before, according to the latest official Home Office data seen by Business of Cannabis.
Cannabis Europa London returns on 26-27 May 2026, bringing together operators, investors, clinicians and policymakers from across the global cannabis industry for two days of main stage debate, exhibition, and networking.
The third annual Business of Cannabis Awards ceremony is fast approaching, and with submissions closing on May 13, time is running out to complete your submissions.
The shortlist for the second annual Business of Cannabis Awards, Europe’s leading celebration of excellence across the cannabis sector, have been announced today.
Today, Cannabis Europa 2025 welcomed hundreds of the world’s leading cannabis voices for its first jam packed day of sessions.
